Skip to main content
AVLS Congress and UIP 2023 World Congress Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Stream Session
Live Stream Session
Ticketed Event
Ticketed Event
Invitation Only
Invitation Only
Translation
Translation
Recorded Content
Recorded Content
CME
CME
Non-CME
Non-CME
Back
Watch Recording

General Session
Livestream

Keynote - Debate Sessions 2.0

Tuesday, September 19, 2023
4:30 PM – 6:00 PM US EDT
Location: Grand Ballroom B
CE: 1.5

Live Stream Session Translation Recorded Content CME

    Chair(s)

  • John Blebea, MD, MBA

    Clinical Professor of Surgery
    Central Michigan University
    Central Michigan University
    Saginaw, MI, United States

    Disclosure(s):

    The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.

    • Co-Chair(s)

  • Alun Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FLSW, FACPh

    Professor of Vascular Surgery
    Section of Vascular Surgery, Imperial College London
    Imperial College
    London, England, United Kingdom

    Disclosure(s):

    The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.

    PDF

  • Kathleen Gibson, MD, FACS, FAVLS

    Congress President
    Lake Washington Vascular Surgeons
    Bellevue, Washington, United States

    Disclosure(s): Boston Scientific: Consultant/Advisory Board, Other Research Support, Speaker/Honoraria; Gore: Consultant/Advisory Board, Research Grant; Janssen: Speaker/Honoraria; Koya: Consultant/Advisory Board; Medtronic: Consultant/Advisory Board, Other Research Support, Research Grant, Speaker/Honoraria; Philips: Consultant/Advisory Board, Speaker/Honoraria

  • Fedor Lurie, MD, PhD (he/him/his)

    UIP Research Chair
    Jobst Vascular Institute
    University of Michigan
    Toledo, Ohio, United States

    Disclosure(s): Sigvar: Speaker/Honoraria

  • MM

    Mark Meissner, MD

    Peter Gloviczki Professor of Venous and Lymphatic Disorders
    University of Washington
    University of Washington School of Medicine
    Seattle, WA, United States

    Disclosure(s):

    The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.

    PDF

Debate Sessions

Learning Objectives:

  • To learn different points of view on key clinical aspects of CVD.
  • To increase our understanding of venous and lymphatic diseases through debates on the key issues.
  • To learn different points of view on key clinical aspects of CVD.

Presentations:

  • 4:30 PM – 6:00 PM US EDT
    Keynote - Debate Sessions 2.0

    Chair: John Blebea, MD, MBA – Central Michigan University

    Co-Chair: Alun H. Davies, MA DM DSc FRCS FACPh – Imperial College London

    Co-Chair: Kathleen Gibson, MD, FACS, FAVLS – Lake Washington Vascular Surgeons

    Co-Chair: Fedor Lurie, MD, PhD (he/him/his) – Jobst Vascular Institute

    Co-Chair: Mark Meissner, MD – University of Washington

  • 4:31 PM – 4:35 PM US EDT
    Welcome

    Chair: John Blebea, MD, MBA – Central Michigan University

  • 4:35 PM – 4:45 PM US EDT
    What Evidence Do We Need to See Before a Technique Is Adopted?

    Keynote Speaker: Erin H. Murphy, MD, FACS – Sanger Heart and Vascular, Atrium Health, North Carolina

  • 4:45 PM – 4:55 PM US EDT
    What Is the Role of Pharmaceuticals in Management of Primary Venous Disease?

    Keynote Speaker: Monika L. Gloviczki, MD, PhD – Mayo Clinic

  • 4:55 PM – 5:20 PM US EDT
    Debate 2.1: Societal Guidelines Are They Worth the Effort?

    Debate Moderator: John Blebea, MD, MBA – Central Michigan University

  • 4:56 PM – 5:20 PM US EDT
    Against: Societal Guidelines Are They Worth the Effort?

    Debater - Con: Alun H. Davies, MA DM DSc FRCS FACPh – Imperial College London

  • 4:56 PM – 5:20 PM US EDT
    Pro: Societal Guidelines Are They Worth the Effort?

    Debater - Pro: Mark Meissner, MD – University of Washington

  • 5:20 PM – 6:00 PM US EDT
    Debate 2.2: Rationing Vein Care Is Key to a Sustainable Health System

    Debate Moderator: John Blebea, MD, MBA – Central Michigan University

  • 5:21 PM – 6:00 PM US EDT
    Against: Rationing Vein Care Is Key to a Sustainable Health System

    Debater - Con: Dan Carradice, MBChB, FRCS, MD (Hon), PGC Med US, PGD Health Econ (he/him/his) – Hull York Medical School

  • 5:21 PM – 6:00 PM US EDT
    Against: Rationing Vein Care Is Key to a Sustainable Health System

    Debater - Con: Sergio Gianesini, MD, PhD, FACS – University of Ferrara

  • 5:21 PM – 6:00 PM US EDT
    Pro: Rationing Vein Care Is Key to a Sustainable Health System

    Debater - Pro: Ravul Jindal, MS, DNB, FRCS, FIVS – Fortis Hospital Mohali

  • 5:21 PM – 6:00 PM US EDT
    Pro: Rationing Vein Care Is Key to a Sustainable Health System

    Debater - Pro: Jose I. Almeida, MD – Miami Vein